Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cells

Clinical Cancer Research

Volumn 15, Issue 7, 2009, Pages 2222-2230

  Kanazawa, Takeharu ^a,b   Kommareddi, Pavan K ^a   Iwashita, Toshihide ^c   Kumar, Bhavna ^a   Misawa, Kiyoshi ^a,d   Misawa, Yuki ^a,d   Jang, Ilwhan ^a   Nair, Thankam S ^a   Iino, Yukiko ^b   Carey, Thomas E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CASPASE 3; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 1C; DNA FRAGMENT; GALANIN; GALANIN RECEPTOR 1; GALANIN RECEPTOR 2; GALANIN RECEPTOR 3; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL COUNT; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; GENETIC TRANSFECTION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; MUTANT; NEUROBLASTOMA CELL; P53 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STAINING; UPREGULATION; WILD TYPE;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CASPASE 3; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASE INHIBITOR P57; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; MUTATION; RECEPTOR, GALANIN, TYPE 2;

EID: 65249160571     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-2443     Document Type: Article

References (41)

1. NishinoH, Miyata M, Morita M, Ishikawa K, Kanazawa T, Ichimura K. Combined therapy with conservative surgery, radiotherapy, and regional chemotherapy for maxillary sinus carcinoma. Cancer 2000;89: 1925-32.
2. Hill SJ. G-protein-coupled receptors: past, present and future. Br J Pharmacol 2006;147:S27-37.
3. BergerA, Santic R, Almer D, et al. Galanin and galanin receptors in human gliomas. Acta Neuropathol (Berl) 2003;105:555-60.
4. Berger A, Lang R, Moritz K, et al. Galanin receptor subtype GalR2 mediates apoptosis in SH-SY5Y neuroblastoma cells. Endocrinology 2004;145:500-7.
5. Wittau N, Grosse R, Kalkbrenner F, Gohla A, Schultz G, Gudermann T. The galanin receptor type 2 initiates multiple signaling pathways in small cell lung cancer cells by coupling to G(q), G(i) and G(12) proteins. Oncogene 2000;19:4199-209.
6. Kanazawa T, Iwashita T, Kommareddi P, et al. Galanin and galanin receptor type 1 suppress proliferation in squamous carcinoma cells: activation of the extracellular signal regulated kinase pathway and induction of cyclin-dependent kinase inhibitors. Oncogene 2007; 26:5762-71.
7. Seufferlein T, Rozengurt E. Galanin, neurotensin, and phorbol esters rapidly stimulate activation of mitogen-activated protein kinase in small cell lung cancer cells. Cancer Res 1996;56:5758-64.
8. lishi H, Tatsuta M, Baba M, et al. Inhibition by galanin of experimental carcinogenesis induced by azaserine in rat pancreas. Int J Cancer 1998;75:396-9.
9. Takebayashi S, Hickson A, OgawaT, et al. Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer. Genes Chromosomes Cancer 2004;41:145-54.
10. Takebayashi S, Ogawa T, Jung KY, et al. Identification of new minimally lost regions on18q in head and neck squamous cell carcinoma. Cancer Res 2000;60:3397-403.
11. Misawa K, Ueda Y, Kanazawa T, et al. Epigenetic inactivation of galanin receptor 1 in head and neck cancer. Clin Cancer Res 2008;14:7604-13.
12. Krause CJ, CareyTE, Ott RW, Hurbis C, McClatchey KD, Regezi JA. Human squamous cell carcinoma. Establishment and characterization of new permanent cell lines. Arch Otolaryngol 1981;107:703-10.
13. Bradford CR, Zhu S, Ogawa H, et al. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Head Neck 2003;25:654-61.
14. Hauser U, Balz V, Carey TE, et al. Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region. Head Neck 2002;24:868-73.
15. Mandic R, Schamberger CJ, Muller JF, et al. Reduced cisplatin sensitivity of head and neck squamous cell carcinoma cell lines correlates with mutations affecting the COOH-terminal nuclear localization signal of p53. Clin Cancer Res 2005;11: 6845-52.
16. Bauer JA,Trask DK, Kumar B, et al. Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL. Mol CancerTher 2005;4:1096 -104.
17. Oliver CL, Bauer JA, Wolter KG, et al. In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamou s cell carcinoma cells. Clin Cancer Res 2004;10:7757-63.
18. Gorman AM, Orrenius S, Ceccatelli S. Apoptosisin neuronal cells: role of caspases. Neuroreport 1998;9:R49-55.
19. Revankar CM,Vines CM, Cimino DF, Prossnitz ER. Arrestins block G protein-coupled receptor-mediated apoptosis. J Biol Chem 2004;279:24578-84.
20. Bhaskaran M, Reddy K, Radhakrishanan N, Franki N, Ding G, Singhal PC. Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol 2003;284:F955-65.
21. Wang P, Gao H, Ni Y, et al. Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2. J Biol Chem 2003;278: 6363-70.
22. Tofighi R, Joseph B, Xia S, et al. Galanin decreases proliferation of PC12 cells and induces apoptosis via its subtype 2 receptor (GalR2). Proc Natl Acad Sci USA 2008;105:2717-22.
23. Moelling K, Schad K, Bosse M, Zimmermann S, Schweneker M. Regulation of Raf-Akt cross-talk. J Biol Chem 2002;277:31099-106.
24. Gartel AL,Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002;1:639-49.
25. Wang X, Gorospe M, Huang Y, Holbrook NJ. p27 Kip1 overexpression causes apoptotic death of mammalian cells. Oncogene 1997;15:2991-7.
26. Otsubo T, Akiyama Y, Yanagihara K,Yuasa Y SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis. Br J Cancer 2008;98:824-31.
27. Hommura F, Dosaka-Akita H, Mishina T, et al. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers. Clin Cancer Res 2000;6:4073-81.
28. Sgambato A, Migaldi M, Leocata P, et al. Loss of p27Kip1 expression is a strong independent prognostic factor of reduced survival in N0 gastric carcinomas. Cancer 2000;89:2247-57.
29. Mineta H, Miura K, Suzuki I, et al. Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma. Cancer 1999; 85:1011 -7.
30. Fan GK, Xu F, Yang B, Fujieda S. p57(kip2) expression is related to carcinogenesis and tumor progression in laryngeal tissues. Acta Otolaryngol 2006;126: 301-5.
31. Kenny FS, Hui R, Musgrove EA, et al. Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer. Clin Cancer Res 1999;5:2069-76.
32. Kong S, Amos CI, Luthra R, Lynch PM, Levin B, Frazier ML. Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res 2000;60:249-52.
33. Akervall J, Bockmuhl U, Petersen I, YangK, Carey TE, Kurnit DM. The gene ratios c-MYC:cyclin-dependent kinase (CDK) N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck. Clin Cancer Res 2003;9:1750-5.
34. Clarke AR, Purdie CA, Harrison DJ, et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993;362:849-52.
35. Holmberg C, Helin K, Sehested M, Karlstrom O. E2F-1-induced p53-independent apoptosis in transgenic mice. Oncogene 1998;17:143-55.
36. Putzer BM, Stiewe T, Parssanedjad K, Rega S, Esche H. E1A is sufficient by itself to induce apoptosis independent of p53 and other adenoviral gene products. Cell Death Differ 2000;7:177-88.
37. Urist M, Tanaka T, Poyurovsky MV, Prives C. p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2. Genes Dev 2004;18:3041 -54.
38. Lasfer M, Vadrot N, Schally AV, et al. Potent induction of apoptosis in human hepatoma cell lines by targeted cytotoxic somatostatin analogue AN-238. J Hepatol 2005;42:230-7.
39. Ammoun S, Lindholm D, Wootz H, Akerman KE, Kukkonen JP. G-protein-coupled OX1 orexin/hcrtr-1 hypocretin receptors induce caspase-dependent and -independent cell death through p38 mitogen-/stress-activated protein kinase. J Biol Chem 2006; 281:834-42.
40. Moll UM, LaQuaglia M, Benard J, Riou G. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci U S A 1995;92: 4407-11.
41. Shibata T, Iio K, Kawai Y, et al. Identification of a lipid peroxidation product as a potential trigger of the p53 pathway. J Biol Chem 2006;281:1196-204.